MINDS: Noninvasive Brain Stimulation to Enhance Cognitive Training in Older Adults

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT04050046
Collaborator
(none)
28
2
35.4

Study Details

Study Description

Brief Summary

This research study explores the feasibility of pairing computer-based cognitive training (CBCT) with transcranial direct current stimulation (tDCS), a form of non-invasive brain stimulation, in order to enhance and preserve mental skills in older adults. The investigators aim to enhance participants ability to perform tasks of memory, attention, processing speed and other areas of cognition. Additionally, researchers are interested in the ability of the brain to adapt to change-neuroplasticity. Neuroplasticity is thought to impact how individuals respond to cognitive training and tDCS. In order to look at individual differences in neuroplasticity transcranial magnetic stimulation (TMS), a noninvasive brain stimulation technique, will be used. Individual responses to TMS can be used as a marker of neuroplastic changes in brain function, in order to reveal the relationship between brain plasticity and tDCS-induced changes in cognitive ability.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcranial Direct Current Stimulation
  • Behavioral: Computer-based cognitive therapy (CBCT)
N/A

Detailed Description

Promising evidence suggests that cognitive training regimens may have some beneficial effects on cognition in older adults. However, the improvement from computer-based cognitive training (CBCT) diminish over time which highlights a fundamental challenge for CBCT interventions. Transcranial direct current stimulation (tDCS) can enhance certain cognitive skills, particularly when stimulation is combined with rehearsal of relevant behaviors. Importantly, these benefits have been shown to persist up to 2 months after the intervention.

This study will lay the groundwork for larger scale studies that will combine CBCT with neuromodulation, potentially leading to the development of a persistent, transferrable, multimodal technique to preserve cognition in older adults. In this study, participants will be randomly assigned to receive either real or sham tDCS for 5 consecutive days in conjunction with CBCT. The participant's cognition will be assessed with a neuropsychological assessment at baseline, 1 week, 2 weeks, and 2 months in order to determine any changes.

Additionally, transcranial magnetic stimulation (TMS) will be used to characterize the relationship between baseline differences in brain plasticity and cognitive changes induced by tDCS+CBCT. The effects of TMS on cortical activity have been shown to depend on a variety of neuroplasticity-related mechanisms. In this study, changes in motor physiology (called motor evoked potentials (MEPs)) induced by TMS will be used. Stimulation of the motor cortex with TMS induces robust, transient, and readily quantifiable changes in motor excitability, which are sensitive to changes in the mechanisms of neuroplasticity. Investigators hypothesize that individual variability in brain plasticity, measured by changes in MEP response to TMS, will predict the degree of cognitive benefit afforded by tDCS+CBCT.

Study Visits:

---------------- Visit 1 - Consent and Screening (2 hours) Review enrollment documents and conduct baseline neuropsychological assessment

---------------- Visit 2 - Visit 5 - tDCS + CBCT (30 minutes) Subjects will receive either real or sham stimulation along with cognitive training

--------------- Visit 6 - tDCS + CBCT & Follow-up (3 hours) Subjects will receive either real or sham stimulation along with cognitive training & follow-up neurospychological assessment

--------------- Visit 7 - TMS (3 hours) Subjects will receive TMS in order to induce MEPs

------------ Visit 8 - 2 week follow-up (1 .5 hours) Follow-up neuropsychological assessment

----------- Visit 9 - 2 month follow-up (1.5 hours) Follow-up neuropsycological assessment

Study Design

Study Type:
Interventional
Actual Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants are assigned to either receive real or sham tDCS without the option of crossover.Participants are assigned to either receive real or sham tDCS without the option of crossover.
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Noninvasive Brain Stimulation to Enhance Cognitive Training and Assess Neuroplasticity in Older Adults
Actual Study Start Date :
Aug 18, 2015
Actual Primary Completion Date :
Aug 1, 2018
Actual Study Completion Date :
Aug 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Real tDCS + CBCT

20 minutes of 2.0mA of tDCS for 5 consecutive days

Device: Transcranial Direct Current Stimulation
tDCS is a neuromodulatory technique that delivers a small electric current (about the equivalent of a 9V battery) to the head. A fixed current between 1 and 2 mA is typically applied. tDCS works by applying a positive (anodal) or negative (cathodal) current via electrodes to an area, facilitating the depolarization or hyperpolarization of neurons, respectively.

Behavioral: Computer-based cognitive therapy (CBCT)
Repetitive, drill-like training usually presented in the form of a game that targets a specific cognitive construct.

Sham Comparator: Sham + CBCT

Sham stimulation closely imitates reals tDCS 30 second ramp-up / ramp-down

Device: Transcranial Direct Current Stimulation
tDCS is a neuromodulatory technique that delivers a small electric current (about the equivalent of a 9V battery) to the head. A fixed current between 1 and 2 mA is typically applied. tDCS works by applying a positive (anodal) or negative (cathodal) current via electrodes to an area, facilitating the depolarization or hyperpolarization of neurons, respectively.

Behavioral: Computer-based cognitive therapy (CBCT)
Repetitive, drill-like training usually presented in the form of a game that targets a specific cognitive construct.

Outcome Measures

Primary Outcome Measures

  1. Executive Function [baseline, day 5, 2 week, 2 months]

    Change in tDCS induced executive function as measured by the Delis-Kaplan Executive Function Systems (DKEFS) test. DKEFS utilizes a scaled score which ranges from 1-20 with scores between 8-12 considered average.

Secondary Outcome Measures

  1. TMS brain activation [2 week]

    Change in average amplitude of MEPs as a response to TMS. We expect to see an initial reduction (or inhibition) in average amplitude of the MEP response to TMS, followed by a return to baseline amplitude.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Normal cognition

  • English as their native language

Exclusion Criteria:
  1. . History of neurological disorders

  2. . History of head injury with unconsciousness lasting more than 5 minutes

  3. . History of psychiatric disorders

  4. . Currently abusing alcohol or drugs (prescription or otherwise)

  5. . History of epilepsy or seizures within the past 6 months

  6. . Previous brain surgery

  7. . Pacemaker

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Pennsylvania

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT04050046
Other Study ID Numbers:
  • 822954
First Posted:
Aug 8, 2019
Last Update Posted:
Feb 11, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Pennsylvania

Study Results

No Results Posted as of Feb 11, 2021